Accessibility Menu
Nexgel logo

Nexgel(NASDAQ) NXGL

Market Cap$4.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-88%
5 YearN/A
1 Year-82%
1 Month-16%
$0.44
-0.57%
-0.00Today
Nexgel last closing stock price
MetricPriceDate
Last closeUSD 0.442026-07-27
Nexgel stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.02%USD 0.452026-07-20
1 month-16.04%USD 0.522026-06-26
3 month-27.97%USD 0.612026-04-28
Year to date-72.89%USD 1.612025-12-31
1 year-81.5%USD 2.362025-07-25
3 year-78.81%USD 2.062023-07-28
Since inception-87.53%USD 3.522021-12-22

Nexgel Financials at a Glance

Market Cap

$4.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.26M

Net Income (TTM)

-$3.22M

EPS (TTM)

-$0.40

P/E Ratio

-1.09

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.44

Volume

36,717.063

Open

$0.46

Previous Close

$0.44

Daily Range

$0.43 - $0.46

52-Week Range

$0.41 - $2.89

Estimated Earnings Date

Aug 11, 2026

NXGL News

Foolcom-Featured.png

Nexgel Revenue Jumps 100% in Fiscal Q2

Motley Fool Markets TeamAug 12, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexgel

NEXGEL makes gel-based products for wound care and skincare. Its products help people with sensitive skin or minor injuries. The company also supplies gels for medical and cosmetic uses.

Sticky Solutions: What NEXGEL Sells

  • Branded Consumer Products: Over-the-counter wound care, skincare, and beauty items for direct consumers.
  • Contract Manufacturing: Bulk hydrogel materials for other companies to use in their products.
  • Custom & White Label: Tailored gel products made for other brands, including ingredient-infused masks.
  • Medical Devices (Developmental): Surgical drapes and adhesive tapes for hospitals and clinics, not yet commercialized.
  • Other: Freight and logistics services for online sales channels like Amazon and Shopify.

Growth Spurts and New Gels: Expansion Moves

  • Acquired Silly George beauty brand in May 2024 to expand consumer offerings.
  • Formed a joint venture with CG Converting and Packaging for finished goods manufacturing.
  • Partnered with STADA Arzneimittel AG in July 2025, receiving a $1 million advance for product launches.
  • Launched new medical device lines (NEXDrape, NEXDerm) for future licensing or partnerships.
  • Increased e-commerce presence through Amazon and Shopify since 2024.

Why NEXGEL Sticks Out

NEXGEL uses a unique electron beam process to make skin-friendly gels. Its manufacturing can scale quickly, supporting both custom and branded products. The company reaches customers through online, retail, and medical channels.

Five Things You Need to Know

  • Revenue was $11.4 million in 2025, up 31.5% from 2024.
  • Branded consumer products made up 64.1% of 2025 revenue.
  • Gross profit margin rose to 39.5% in 2025 from 31.6% in 2024.
  • Net loss was $3.0 million in 2025, improving from $3.3 million in 2024.

Bottom Line

NEXGEL has shifted from contract manufacturing to branded consumer products and medical devices. The company continues to diversify and adapt in a competitive healthcare market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

19

CEO

Adam D. Levy

Website

www.nexgel.com

Headquarters

Langhorne, PA 19047, US

NXGL Financials

Key Financial Metrics (TTM)

Gross Margin

38.89%

Operating Margin

-31.37%

Net Income Margin

-28.54%

Return on Equity

-70.23%

Return on Capital

-44.41%

Return on Assets

-27.72%

Earnings Yield

-91.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

9.23M

Volume

36.72K

Avg. Volume

249.47K

Financials (TTM)

Gross Profit

$4.38M

Operating Income

-$3.53M

EBITDA

-$2.24M

Operating Cash Flow

-$1.42M

Capital Expenditure

-$9.00K

Free Cash Flow

-$1.42M

Cash & ST Invst.

$208.00K

Total Debt

$4.29M

Nexgel Performance Analysis

Nexgel annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,048,00032.0%
20232023-12-31USD 4,089,00099.7%
20242024-12-31USD 8,688,000112.5%
20252025-12-31USD 11,421,00031.5%
Nexgel sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-302.8%
Q32025-09-301.7%
Q42025-12-31-4.7%
Q12026-03-31-5.2%
Nexgel annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.8510.1%
20232023-12-31USD -0.56-34.6%
20242024-12-31USD -0.50-9.5%
20252025-12-31USD -0.38-24.2%
Nexgel sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-306.7%
Q32025-09-307.9%
Q42025-12-31-50.0%
Q12026-03-318.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.65M

-5.6%

Gross Profit

$1.06M

-10.7%

Gross Margin

40.04%

N/A

Market Cap

$4.03MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$211.94K

N/A

Employees

19

N/A

Net Income

-$927.00K

-30.2%

EBITDA

-$657.00K

-23.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$208.00K

-82.6%

Total Debt

$4.29M

+56.3%

Accounts Receivable

$662.00K

-28.5%

Inventory

$2.26M

+22.6%

Long Term Debt

$3.80M

+61.8%

Short Term Debt

$484.00K

+23.5%

Return on Assets

-27.72%

N/A

Return on Invested Capital

-42.65%

N/A

Free Cash Flow

-$513.00K

-28.2%

Operating Cash Flow

-$504.00K

-26.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MTVAMetaVia Inc.
$1.45-2.03%
FEMYFemasys Inc.
$3.06-17.52%
NXLNexalin Technology, Inc.
$0.44-8.15%
GDTCCytoMed Therapeutics Limited
$0.90-9.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%

Questions About NXGL

What is the current price of Nexgel?

Nexgel is trading at $0.44 per share.

What is the 52-week range for Nexgel?

Over the past 52 weeks, Nexgel has traded between $0.41 and $2.89.

How much debt does Nexgel have?

As of the most recent reporting period, Nexgel reported total debt of $4.29M.

How much cash does Nexgel have on hand?

Nexgel reported $2.12M in cash and cash equivalents in its most recent financial results.

What is Nexgel’s dividend yield?

Nexgel does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services